How Drugs of Abuse Including Cannabis Affect the Immune System and Infection Risk
A review found that marijuana, opiates, cocaine, nicotine, and alcohol all suppressed immune function through receptor-mediated mechanisms, increasing susceptibility to infections including in the context of HIV/AIDS.
Quick Facts
What This Study Found
The review described how multiple drugs of abuse, including marijuana, modulated the immune system. For marijuana and opiates, immunosuppressive effects were receptor-mediated, occurring both directly through receptors on immune cells and indirectly through receptors in the nervous system. Cocaine and nicotine showed similar receptor-mediated immunomodulatory effects.
The immunosuppressive properties of these drugs increased susceptibility to opportunistic infections, which became an urgent public health concern with the AIDS epidemic. The review noted a long-recognized relationship between drug abuse and increased infection levels, with mechanistic research providing explanations for this clinical observation.
Key Numbers
No specific quantitative data were presented in the abstract.
How They Did This
This was a narrative review covering the immunomodulatory mechanisms of marijuana, opiates, cocaine, nicotine, and alcohol, synthesizing evidence from basic science, immunology, and clinical observations of infection susceptibility.
Why This Research Matters
Understanding how cannabis affects the immune system has dual significance: it explains increased infection susceptibility in cannabis users and points toward potential therapeutic applications of cannabinoid immunomodulation in autoimmune and inflammatory conditions. The receptor-mediated nature of these effects suggested they could potentially be targeted pharmacologically.
The Bigger Picture
The immunomodulatory properties of cannabinoids have since been investigated for therapeutic applications in autoimmune diseases and inflammatory conditions. The finding that CB2 receptors on immune cells mediate many of these effects has led to research on CB2-selective drugs that could modulate immunity without psychoactive effects.
What This Study Doesn't Tell Us
The review covered five different drug classes broadly, limiting depth on cannabis specifically. Much of the evidence was from in vitro and animal studies. The clinical significance of cannabinoid immunosuppression in otherwise healthy users remained unclear.
Questions This Raises
- ?Does cannabis immunosuppression translate to clinically meaningful increases in infection risk for typical users?
- ?Can the immunomodulatory properties of cannabinoids be harnessed for treating autoimmune conditions?
Trust & Context
- Key Stat:
- Cannabis immunosuppression is receptor-mediated, occurring on immune cells and in the nervous system
- Evidence Grade:
- This is a narrative review synthesizing immunological and pharmacological evidence across multiple drugs, providing moderate-level evidence.
- Study Age:
- Published in 2003. Subsequent research has refined understanding of cannabinoid immunomodulation and explored therapeutic applications.
- Original Title:
- Microbial infections, immunomodulation, and drugs of abuse.
- Published In:
- Clinical microbiology reviews, 16(2), 209-19 (2003)
- Authors:
- Friedman, Herman, Newton, Catherine, Klein, Thomas W(2)
- Database ID:
- RTHC-00136
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Does cannabis weaken the immune system?
This review found that cannabis has immunosuppressive effects mediated through cannabinoid receptors on immune cells. Whether this translates to clinically meaningful infection risk for typical users is less clear, but the effect is documented in both laboratory and animal studies.
Could cannabis immune effects be used therapeutically?
The immunosuppressive properties of cannabinoids have been investigated for potential use in autoimmune and inflammatory conditions, where dampening the immune response would be beneficial. CB2-selective compounds are being explored for this purpose.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
- cannabis-and-ibs-gut-health-inflammation
- cannabis-and-crohns-disease-gastroenterology
Cite This Study
https://rethinkthc.com/research/RTHC-00136APA
Friedman, Herman; Newton, Catherine; Klein, Thomas W. (2003). Microbial infections, immunomodulation, and drugs of abuse.. Clinical microbiology reviews, 16(2), 209-19.
MLA
Friedman, Herman, et al. "Microbial infections, immunomodulation, and drugs of abuse.." Clinical microbiology reviews, 2003.
RethinkTHC
RethinkTHC Research Database. "Microbial infections, immunomodulation, and drugs of abuse." RTHC-00136. Retrieved from https://rethinkthc.com/research/friedman-2003-microbial-infections-immunomodulation-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.